This concept is in agreement with the finding that IL-9 promotes the development of many hematological human tumors, including Hodgkin’s lymphoma and B cell lymphoma (56) suggesting the presence of pro-tumoral effects of IL-9 in several tumor entities. Here, IL9 is linked to B-cell non-Hodgkin lymphoma.